The second phase of testing a new type of inactivated vaccine against coronavirus, developed by the Wuhan Institute of Biological Products under the State Pharmaceutical Corporation of China and the Wuhan Institute of Virology of the Chinese Academy of Sciences, began in China, Xinhua News Agency reported. The second test phase will focus on the vaccination procedure.
In the first phase of testing, 96 people from three different age groups received the vaccine. As long as the product shows good safety, surveillance of vaccine recipients continues.
The Institute notes that there will be the third phase of clinical trials. In general, the whole process can take about a year, and only after the end of the tests will it be possible to draw conclusions about the safety and effectiveness of the drug.
Copyright © 2023 The Eastern Herald.
For the latest updates and news follow The Eastern Herald on Google News, Instagram, Facebook, and Twitter.
Help us continue our mission to deliver the latest news and stories by becoming a supporter of our newspaper. Your support will help us to continue to provide high-quality journalism and to ensure that our content remains free and accessible to all. Click here to show your support. Thank you!